Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Central nervous system neuroinflammatory disorders in Asian/Pacific regions.
Cervical cord and ventricle affection in neuromyelitis optica.
Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. PRISMS (Prevention of Relapses and Disability by Interferon beta-1a Subcutaneously in Multiple Sclerosis) Study Group.
Developing a Valuation Function for the Preference-Based Multiple Sclerosis Index: Comparison of Standard Gamble and Rating Scale.
Neuromyelitis optica spectrum disorders: Comparison according to the phenotype and serostatus.
A novel adaptive design strategy increases the efficiency of clinical trials in secondary progressive multiple sclerosis.
Cost-effectiveness of glatiramer acetate and interferon beta-1a for relapsing-remitting multiple sclerosis, based on the CombiRx study.
Gastro Effects Dog Oral MS Drug Tecfidera
Immunology of Multiple Sclerosis.
Alpha/beta interferon is a neuronal growth factor.
Multiple sclerosis: Could Helicobacter pylori provide protection against multiple sclerosis?
Clinical Significance of Gastrointestinal and Flushing Events in Patients with Multiple Sclerosis Treated with Delayed-Release Dimethyl Fumarate.
EMD Serono and Pfizer announce FDA approval of Rebif® Rebidose® (interferon beta-1a)
Betaseron (Interferon Beta-1b) for SC Injection
Hypovitaminosis D upscales B-cell immunoreactivity in multiple sclerosis.
Rituximab for relapsing-remitting multiple sclerosis.
Pre-specified subgroup analyses of a placebo-controlled phase III trial (TEMSO) of oral teriflunomide in relapsing multiple sclerosis.
Parenteral Treatment of Multiple Sclerosis: The Advent of Monoclonal Antibodies.
Sema4A inhibits the therapeutic effect of IFN-β in EAE.
Differential transcriptional response profiles in human myeloid cell populations.
Dimethyl fumarate protects pancreatic islet cells and non-endocrine tissue in L-arginine-induced chronic pancreatitis.
Inhibition of LTi Cell Development by CD25 Blockade Is Associated with Decreased Intrathecal Inflammation in Multiple Sclerosis.
Effects of BG-12 (dimethyl fumarate) on health-related quality of life in patients with relapsing-remitting multiple sclerosis: findings from the CONFIRM study.
Drugs@FDA
Interferon-beta1b for the treatment of multiple sclerosis.

Pages